DN2 cells are the predominant B-cell population in active SLE; they tend to develop into plasma cells and exhibit high levels of CD11c and T-Bet expression but low levels of CXCR5 and CD62L expression (12). The gene discussed is TBX21; the disease is systemic lupus erythematosus.